GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Price-to-Operating-Cash-Flow

Hisamitsu Pharmaceutical Co (TSE:4530) Price-to-Operating-Cash-Flow : (As of May. 12, 2024)


View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Price-to-Operating-Cash-Flow?

As of today (2024-05-12), Hisamitsu Pharmaceutical Co's share price is 円3823.00. Hisamitsu Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Nov. 2023 was 円0.00. Hence, Hisamitsu Pharmaceutical Co's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Hisamitsu Pharmaceutical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

TSE:4530' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 15.45   Med: 38.5   Max: 38.99
Current: 15.92

During the past 13 years, Hisamitsu Pharmaceutical Co's highest Price-to-Operating-Cash-Flow Ratio was 38.99. The lowest was 15.45. And the median was 38.50.

TSE:4530's Price-to-Operating-Cash-Flow is ranked better than
55.03% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.73 vs TSE:4530: 15.92

Hisamitsu Pharmaceutical Co's Cash Flow from Operations per share for the three months ended in Nov. 2023 was 円0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Nov. 2023 was 円0.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Hisamitsu Pharmaceutical Co was 49.80% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 54.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 0.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -7.70% per year.

During the past 13 years, Hisamitsu Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 54.80% per year. The lowest was -43.80% per year. And the median was 5.70% per year.


Hisamitsu Pharmaceutical Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Price-to-Operating-Cash-Flow Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.52 102.67 15.49 23.83 16.13

Hisamitsu Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.83 - - - -

Competitive Comparison of Hisamitsu Pharmaceutical Co's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.



Hisamitsu Pharmaceutical Co Price-to-Operating-Cash-Flow Calculation

Hisamitsu Pharmaceutical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=3823.00/0
=

Hisamitsu Pharmaceutical Co's Share Price of today is 円3823.00.
Hisamitsu Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Hisamitsu Pharmaceutical Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines